The MLT's in vitro modified release profile in gastrointestinal-like fluids was probed.
For comparison, tablets were also tested under the USP method established for modified release mesalamine formulations.
This means that several functions apply, spreading from the stabilization and modified release, to providing biocompatible properties and targeting moieties.
In this article, we review system design, various constructions and formulation parameters of modified release dosage forms.
In contrast, using the USP dissolution method, normally employed for modified release mesalamine products, no discrimination was attained.
The study demonstrated a unique application of a texture analyzer in characterization of modified release matrix tablets.
This work has demonstrated the potential of combining FDM 3DP with established pharmaceutical processes, including HME and film coating, to fabricate modified release oral dosage forms.
To improve the compliance and quality of life of transplant patients, a once-daily modified release (MR) formulation is an attractive option.
Oral liquids are often preferred for drug administration to patients for whom swallowing is difficult, however, formulating modified release versions can be challenging.
Specific cases are discussed starting with an emphasis on poorly soluble compounds, then the topics of chemically labile drugs, low-dose compounds, and modified release are reviewed.
DFA-02 is an investigational bioresorbable modified release gel consisting of both gentamicin (16.8 mg/mL) and vancomycin (18.8 mg/mL).
